Journal of Epilepsy Research

Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study

Benjamin T. Trevitt, Sasha Bailey, Llewellyn Mills, Thomas R. Arkell, Anastasia Suraev, Iain S. McGregor, Nicholas Lintzeris, Andrea Mastinu

Decoding epilepsy treatment: A comparative evaluation contrasting cannabidiol pharmacokinetics in adult and paediatric populations

Mohamed Osman, Jamileh Khalil, Mostafa El-Bahri, Jamal Swalah Mcdahrou, Reem Fahda, Reymin Mustafa, Arthur Ooi, Marwa Attayee, Rachelle Catanzariti, Lisa Pont, Kylie Williams, Stewart Yeung, Kamal Dua, Gabriele De Rubis, Raimar Loebenberg

Chemico-Biological Interactions.2024; 394: 110988. CrossRef

Examining population structure across multiple collections of Cannabis

Anna Halpin-McCormick, Karolina Heyduk, Michael B. Kantar, Nicholas L. Batora, Rishi R. Masalia, Kerin B. Law, Eleanor J. Kuntz

Genetic Resources and Crop Evolution.2024;[Epub] CrossRef

Discovery of Latent Cannabichromene Cyclase Activity in Marine Bacterial Flavoenzymes

Anna C. Love, Trevor N. Purdy, Felix M. Hubert, Ella J. Kirwan, Darren C. Holland, Bradley S. Moore

Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials

International Journal of Molecular Sciences.2024; 25(7): 3603. CrossRef

Cannabinoides en epilepsia: eficacia clínica y aspectos farmacológicos

Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets

Annals of Neurosciences.2023; 30(4): 262. CrossRef

Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations

Neurología (English Edition).2023; 38(1): 47. CrossRef

Understanding and Rebalancing: A Rapid Scoping Review of Cannabis Research Among Indigenous People

Miles Schaffrick, Melissa L. Perreault, A. Maxwell P. Jones, Judy Illes

Cannabis and Cannabinoid Research.2023; 8(3): 426. CrossRef

Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program

Jerzy P. Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D. Park, Pilar Pichon Zentil, Anup D. Patel, Elizabeth A. Thiele, Robert T. Wechsler, Daniel Checketts, Farhad Sahebkar

Cannabinoid regulation of neurons in the dentate gyrus during epileptogenesis: Role of CB1R‐associated proteins and downstream pathways

Carlos A. Lafourcade, Fraser T. Sparks, Angelique Bordey, Ursula Wyneken, Michael H. Mohammadi

Somatic and terminal CB1 receptors are differentially coupled to voltage-gated sodium channels in neocortical neurons

Luke J. Steiger, Timur Tsintsadze, Glynis B. Mattheisen, Stephen M. Smith

MichaelT Okafor, UzoamakaA Okoli, Uwamleeka Opoke, GermaineA Okafor, ElvisN Shu, ChikereA Anusiem

International Journal of Medicine and Health Devel.2023; 28(2): 81. CrossRef

Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy

Silvia Kochen, Manuela Villanueva, Liliana Bayarres, Anilu Daza-Restrepo, Silvia Gonzalez Martinez, Silvia Oddo

Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy

Eleonora Aronica, Nicola Specchio, Mark J Luinenburg, Paolo Curatolo

Nationwide Study of Postlegalization Marijuana Use Among Patients With Epilepsy in Canada

Caroline Esmonde-White, Richard S. McLachlan, Jorge Burneo, Jayme Arts, Carmela Redhead, Ana Suller Marti

Poly(ethylene glycol)-b-poly(epsilon-caprolactone) nanoparticles as a platform for the improved oral delivery of cannabidiol

Inbar Shreiber-Livne, Liron Sulimani, Anna Shapira, Shiri Procaccia, David Meiri, Alejandro Sosnik

Drug Delivery and Translational Research.2023; 13(12): 3192. CrossRef

Treating Epilepsy with Natural Products: Nonsense or Possibility?

Milan Malaník, Marie Čulenová, Alice Sychrová, Adrianna Skiba, Krystyna Skalicka-Woźniak, Karel Šmejkal

Zhen Xuen Brandon Low, Xin Ru Lee, Tomoko Soga, Bey Hing Goh, Deepa Alex, Yatinesh Kumari

Biomedicine & Pharmacotherapy.2023; 165: 115102. CrossRef

Cannabis: a multifaceted plant with endless potentials

Eric Fordjour, Charles F. Manful, Albert A. Sey, Rabia Javed, Thu Huong Pham, Raymond Thomas, Mumtaz Cheema

Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies

Lucas Brstilo, Gabriela Reyes Valenzuela, Roberto Caraballo, Carlos Pérez Montilla, Facundo García Bournissen, Paulo Cáceres Guido, Paula Schaiquevich

Autism: plants with neuro-psychopharmacotherapeutic potential

Mustafa Sevindik, Falah Saleh Mohammed, Imran Uysal

Prospects in Pharmaceutical Sciences.2023; 21(3): 38. CrossRef

The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study

Aaron J. Rozental, Brooke G. Weisbeck, Isabella Corsato Alvarenga, Daniel L. Gustafson, Breonna R. Kusick, Sangeeta Rao, Lisa R. Bartner, Stephanie McGrath

Journal of Veterinary Internal Medicine.2023; 37(6): 2291. CrossRef

An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy

Francesca Marchese, Maria Stella Vari, Ganna Balagura, Antonella Riva, Vincenzo Salpietro, Alberto Verrotti, Rita Citraro, Simona Lattanzi, Carlo Minetti, Emilio Russo, Pasquale Striano

Cannabis and Cannabinoid Research.2022; 7(2): 199. CrossRef

Evaluation of the Possible Anticonvulsant Effect of Δ9-Tetrahydrocannabinolic Acid in Murine Seizure Models

Melissa J. Benson, Lyndsey L. Anderson, Ivan K. Low, Jia Lin Luo, Richard C. Kevin, Cilla Zhou, Iain S. McGregor, Jonathon C. Arnold

Cannabis and Cannabinoid Research.2022; 7(1): 46. CrossRef

Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg

Andrew J. Roebuck, Quentin Greba, Timothy J. Onofrychuk, Dan L. McElroy, Thaísa M. Sandini, Ayat Zagzoog, Jonathan Simone, Stuart M. Cain, Terrance P. Snutch, Robert B. Laprairie, John G. Howland

European Journal of Neuroscience.2022; 55(4): 1063. CrossRef

Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target

Eulla Keimili Fernandes Ferreira Cavalheiro, Ana Beatriz Costa, Daniéle Hendler Salla, Mariella Reinol da Silva, Talita Farias Mendes, Larissa Espindola da Silva, Cristini da Rosa Turatti, Rafael Mariano de Bitencourt, Gislaine Tezza Rezin

Cannabis and Cannabinoid Research.2022; 7(2): 135. CrossRef

Developmental Medicine & Child Neurology.2022; 64(2): 162. CrossRef

Deepika E. Slawek, Susanna A. Curtis, Julia H. Arnsten, Chinazo O. Cunningham

Medical Clinics of North America.2022; 106(1): 131. CrossRef

Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome

Cristina Alonso, Valentina Satta, Paula Díez-Gutiérrez, Javier Fernández-Ruiz, Onintza Sagredo

The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg

Dan L. McElroy, Andrew J. Roebuck, Quentin Greba, Sumanta Garai, Asher L. Brandt, Orhan Yilmaz, Stuart M. Cain, Terrance P. Snutch, Ganesh A. Thakur, Robert B. Laprairie, John G. Howland

IBRO Neuroscience Reports.2022; 12: 121. CrossRef

Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats

Anna-Maria Costa, Fabiana Russo, Lara Senn, Davide Ibatici, Giuseppe Cannazza, Giuseppe Biagini

Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management

Berhanu Geresu Kibret, Sheel Patel, Jonathan Niezgoda, William Guns, Jeffrey Niezgoda, Sandeep Gopalakrishnan, Babak Baban, Paola Cubillos, David Villeneuve, Pritesh Kumar

Advances in Skin & Wound Care.2022; 35(8): 447. CrossRef

International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder

Sam Amin, Marie Monaghan, Angel Aledo-Serrano, Nadia Bahi-Buisson, Richard F. Chin, Angus J. Clarke, J. Helen Cross, Scott Demarest, Orrin Devinsky, Jenny Downs, Elia M. Pestana Knight, Heather Olson, Carol-Anne Partridge, Graham Stuart, Marina Trivisano,

Concerns, beliefs and attitudes of pharmacists and pharmacy students on cannabis use in Canada

Régis Vaillancourt, Rahim Dhalla, Piotr Merks, Taylor Lougheed, Gary Goldfield, Holly Mansell, Jameason Cameron

Canadian Pharmacists Journal / Revue des Pharmacie.2022; 155(4): 219. CrossRef

Potential natural products for the management of autism spectrum disorder

Punya Sachdeva, Intizaar Mehdi, Rohit Kaith, Faizan Ahmad, Md Sheeraz Anwar

Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy

Terence J. O’Brien, Samuel F. Berkovic, Jacqueline A. French, John A. Messenheimer, Terri B. Sebree, Marcel O. Bonn-Miller, Donna L. Gutterman, Manori Wijayath, Peter Patrikios, David Reutens, Joseph Frasca, Udaya Seneviratne, Wendyl D’Souza, Peter Bergin

On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva

Valentina Franco, Michela Palmisani, Roberto Marchiselli, Francesca Crema, Cinzia Fattore, Valentina De Giorgis, Costanza Varesio, Paola Rota, Vincenza Flora Dibari, Emilio Perucca

Lipid nano-carriers loaded with Cannabis sativa extract for epilepsy treatment – in vitro characterization and in vivo efficacy studies

Ljubica Mihailova, Jana Tchekalarova, Dushko Shalabalija, Nikola Geskovski, Veronika Stoilkovska Gjorgievska, Gjoshe Stefkov, Paoleta Krasteva, Maja Simonoska Crcarevska, Marija Glavas Dodov

Journal of Pharmaceutical Sciences.2022; 111(12): 3384. CrossRef

Jag H. Khalsa, Gregory Bunt, Kenneth Blum, Sanjay B. Maggirwar, Marc Galanter, Marc N. Potenza

Current Addiction Reports.2022; 9(4): 630. CrossRef

Heidrun Potschka, Sofie F.M. Bhatti, Andrea Tipold, Stephanie McGrath

The Veterinary Journal.2022; 290: 105913. CrossRef

Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model

Elisa Landucci, Costanza Mazzantini, Daniele Lana, Maura Calvani, Giada Magni, Maria Grazia Giovannini, Domenico E. Pellegrini-Giampietro

Neurobiology of Disease.2022; 174: 105895. CrossRef

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, Domagoj Đikić, Nada Oršolić, Maja Jazvinšćak Jembrek

An overview of liquid chromatographic methods for analyzing new generation anti-epileptic drugs

Mohammed ALSaeedy, Ahmed Hasan, Arwa Al-Adhreai, Ali Alrabie, Hafsah Qaba, Abdulrahman Mashrah, Elif Mine Öncü-Kaya

Journal of Liquid Chromatography & Related Technol.2022; 45(5-8): 66. CrossRef

Cannabinoids: Legal aspects, pharmacology, phytochemistry, probable targets from biological system, and therapeutic potential

Asian Journal of Pharmaceutical Research and Healt.2022; 14(3): 127. CrossRef

Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?

Shimrit Uliel-Sibony, Moran Hausman-Kedem, Aviva Fattal-Valevski, Uri Kramer

Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome

Simona Lattanzi, Gaetano Zaccara, Emilio Russo, Angela La Neve, Monica Anna Maria Lodi, Pasquale Striano

Expert Review of Neurotherapeutics.2021; 21(1): 99. CrossRef

The therapeutic potential of cannabinoids for integumentary wound management

Maximillian A. Weigelt, Raja Sivamani, Hadar Lev‐Tov

Experimental Dermatology.2021; 30(2): 201. CrossRef

Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy

Birgitta Metternich, Kathrin Wagner, Maximilian J. Geiger, Martin Hirsch, Andreas Schulze-Bonhage, Kerstin A. Klotz

Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research

The Past, Present and Future of Cannabis sativa Tissue Culture

Adrian S. Monthony, Serena R. Page, Mohsen Hesami, Andrew Maxwell P. Jones

Behavioral and Molecular Effects Induced by Cannabidiol and Valproate Administration in the GASH/Sal Model of Acute Audiogenic Seizures

Giselda Cabral-Pereira, David Sánchez-Benito, Sandra M. Díaz-Rodríguez, Jaime Gonçalves, Consuelo Sancho, Orlando Castellano, Luis J. Muñoz, Dolores E. López, Ricardo Gómez-Nieto

Frontiers in Behavioral Neuroscience.2021;[Epub] CrossRef

Asymmetric synthesis and in vivo/in vitro characterization of new hybrid anticonvulsants derived from (2,5-dioxopyrrolidin-1-yl)phenylacetamides

Michał Abram, Anna Rapacz, Gniewomir Latacz, Bartłomiej Szulczyk, Justyna Kalinowska-Tłuścik, Dagmara Otto-Ślusarczyk, Marta Struga, Rafał M. Kamiński, Krzysztof Kamiński

White matter integrity after cannabidiol administration for treatment resistant epilepsy

J.T. Houston, R. Nenert, J.B. Allendorfer, E.M. Bebin, T.E. Gaston, A.M. Goodman, J.P. Szaflarski

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

Alix Morel, Pierre Lebard, Alexandra Dereux, Julien Azuar, Frank Questel, Frank Bellivier, Cynthia Marie-Claire, Mélina Fatséas, Florence Vorspan, Vanessa Bloch

Potential of cannabinoids as treatments for autism spectrum disorders

V. Nezgovorova, C.J. Ferretti, B.P. Taylor, E. Shanahan, G. Uzunova, K. Hong, O. Devinsky, E. Hollander

Journal of Psychiatric Research.2021; 137: 194. CrossRef

Postoperative Pain Management Is Influenced by Previous Cannabis Use in Neurosurgical Patients

Kaitlyn Dupriest, Kamryn Rogers, Barsha Thakur, Aardhra M. Venkatachalam, Sonja E. Stutzman

Journal of Neuroscience Nursing.2021; 53(2): 87. CrossRef

Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action

Marcin Ożarowski, Tomasz M. Karpiński, Aleksandra Zielińska, Eliana B. Souto, Karolina Wielgus

International Journal of Molecular Sciences.2021; 22(9): 4294. CrossRef

Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder

Erica Zamberletti, Tiziana Rubino, Daniela Parolaro

Pharmacology & Therapeutics.2021; 226: 107878. CrossRef

GPCR_LigandClassify.py; a rigorous machine learning classifier for GPCR targeting compounds

Marawan Ahmed, Horia Jalily Hasani, Subha Kalyaanamoorthy, Khaled Barakat

Cannabidiol and Neurodevelopmental Disorders in Children

Keith A. Kwan Cheung, Murray D. Mitchell, Helen S. Heussler

Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol

Richard Kanyo, Md Ruhul Amin, Laszlo F. Locskai, Danika D. Bouvier, Alexandria M. Olthuis, W. Ted Allison, Declan W. Ali

The perceived effects of cannabis products in the management of seizures in CDKL5 Deficiency Disorder

Tristan Dale, Jenny Downs, Kingsley Wong, Helen Leonard

Luis A. Martinez, Yi-Chen Lai, J. Lloyd Holder, Anne E. Anderson

Genomic and Chemical Diversity of Commercially Available High-CBD Industrial Hemp Accessions

Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation

Research in Veterinary Science.2021; 140: 38. CrossRef

In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells

Jungnam Kim, Hyunwoo Choi, Eunhye K. Kang, Gil Yong Ji, Youjeong Kim, Insung S. Choi

Cannabidiol – A new fixture in childhood neurology

Current Opinion in Pharmacology.2021; 61: 142. CrossRef

The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models

Jon Egaña-Huguet, Edgar Soria-Gómez, Pedro Grandes

International Journal of Molecular Sciences.2021; 22(24): 13231. CrossRef

Cannabidiol-Loaded Mixed Polymeric Micelles of Chitosan/Poly(Vinyl Alcohol) and Poly(Methyl Methacrylate) for Trans-Corneal Delivery

Alejandro Sosnik, Ronya Ben Shabo, Hen Moshe Halamish

Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence

Rishabh Verma, Farazul Hoda, Mawrah Arshad, Asif Iqubal, Ali Nasir Siddiqui, Mohammad Ahmed Khan, Syed Ehtaishamul Haque, Mohd Akhtar, Abul Kalam Najmi

Medical Cannabis and Cannabinoids.2021; 4(1): 43. CrossRef

Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis

Renandro de Carvalho Reis, Kelson James Almeida, Luciano da Silva Lopes, Cíntia Maria de Melo Mendes, Edson Bor-Seng-Shu

Potential role of cannabidiol for seizure control in a patient with recurrent glioma

Journal of Clinical Neuroscience.2020; 71: 275. CrossRef

Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers

The Journal of Pediatric Pharmacology and Therapeu.2020; 25(1): 75. CrossRef

A North American History of Cannabis Use in the Treatment of Epilepsy

Journal of Clinical Neurophysiology.2020; 37(1): 35. CrossRef

The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights

Willian Lazarini-Lopes, Raquel A. Do Val-da Silva, Rui M.P. da Silva-Júnior, João P. Leite, Norberto Garcia-Cairasco

Neuroscience & Biobehavioral Reviews.2020; 111: 166. CrossRef

Cannabinoids as an alternative option for conventional analgesics in cancer pain management: A pharmacogenomics perspective

Anmi Jose, Levin Thomas, Gayathri Baburaj, Murali Munisamy, Mahadev Rao

Indian Journal of Palliative Care.2020; 26(1): 129. CrossRef

Cannabinoids in the Pathophysiology of Skin Inflammation

Cristian Scheau, Ioana Anca Badarau, Livia-Gratiela Mihai, Andreea-Elena Scheau, Daniel Octavian Costache, Carolina Constantin, Daniela Calina, Constantin Caruntu, Raluca Simona Costache, Ana Caruntu

Possible therapeutic applications of cannabis in the neuropsychopharmacology field

Javier Fernández-Ruiz, Ismael Galve-Roperh, Onintza Sagredo, Manuel Guzmán

European Neuropsychopharmacology.2020; 36: 217. CrossRef

Valorisation and enhanced sustainability of Senegalese sole (Solea senegalensis) aquaculture by dietary use of ditch shrimp (Palaemonetes varians) meal

E. Salas-Leiton, I. Hachero-Cruzado, E. Asensio, C. Vilas, R. Zerolo, J.P. Cañavate

Genomic sequencing in severe epilepsy: a step closer to precision medicine

Mariagrazia Esposito, Ilaria Lagorio, Diego Peroni, Alice Bonuccelli, Alessandro Orsini, Pasquale Striano

Expert Review of Precision Medicine and Drug Devel.2020; 5(2): 101. CrossRef

Cannabinoids Rescue Cocaine-Induced Seizures by Restoring Brain Glycine Receptor Dysfunction

Guichang Zou, Xin Zuo, Kai Chen, Yushu Ge, Xiaoqun Wang, Guangwei Xu, Huan Wang, Chenjian Miao, Zhenyu Xu, Shuangshuang Tian, Zhen Wang, Yifeng Zhou, Wei Wei, Guangming Huang, Dan Liu, Wei Xiong

A Systematic Review of the Protective Actions of Cat’s Whiskers (Misai Kucing) on the Central Nervous System

Yin-Sir Chung, Brandon Kar Meng Choo, Pervaiz Khalid Ahmed, Iekhsan Othman, Mohd. Farooq Shaikh

Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials

Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents

Michał Abram, Anna Rapacz, Szczepan Mogilski, Gniewomir Latacz, Annamaria Lubelska, Rafał M. Kamiński, Krzysztof Kamiński

ACS Chemical Neuroscience.2020; 11(13): 1996. CrossRef

A case of cannabinoid hyperemesis syndrome highlighting related key paediatric issues

Paediatrics & Child Health.2020; 25(Supplement): S7. CrossRef

Biological properties and therapeutic applications of cannabidiol

Costa Glória Elanne, Idalina Torcato de Oliveira Adriana, Fonseca Moreira da Silva Juliana, Sanzio Pimenta Raphael

Journal of Medicinal Plants Research.2020; 14(6): 283. CrossRef

Expectations and knowledge of cannabidiol therapy for childhood epilepsy — A German caregiver survey

Kerstin Alexandra Klotz, Jan Schönberger, Lea Nakamura, Victoria San Antonio-Arce, Thomas Bast, Adelheid Wiemer-Kruel, Susanne Schubert-Bast, Ingo Borggraefe, Steffen Syrbe, Julia Jacobs

Orthosiphon stamineus Proteins Alleviate Pentylenetetrazol-Induced Seizures in Zebrafish

Yin-Sir Chung, Brandon Kar Meng Choo, Pervaiz Khalid Ahmed, Iekhsan Othman, Mohd. Farooq Shaikh

A Survey on Cannabinoid Treatment of Pediatric Epilepsy Among Neuropediatricians in Scandinavia and Germany

Claus Klingenberg, George Mouslet, Helle Hjalgrim, Thorsten Gerstner

John A. Karas, Labell J. M. Wong, Olivia K. A. Paulin, Amna C. Mazeh, Maytham H. Hussein, Jian Li, Tony Velkov

Interactions between cannabidiol and Δ9‐tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome

Lyndsey L. Anderson, Ivan K. Low, Iain S. McGregor, Jonathon C. Arnold

British Journal of Pharmacology.2020; 177(18): 4261. CrossRef

Julie Williams Merten, Benjamin T. Gordon, Jessica L. King, Calista Pappas

Substance Use & Misuse.2020; 55(13): 2213. CrossRef

It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets

Seyed Alireza Salami, Federico Martinelli, Antonio Giovino, Ava Bachari, Neda Arad, Nitin Mantri

Warfarin dose adjustment required after cannabidiol initiation and titration

American Journal of Health-System Pharmacy.2020; 77(22): 1846. CrossRef

Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps

Guilherme Diogo Silva, Felipe Borelli Del Guerra, Maira de Oliveira Lelis, Lécio Figueira Pinto

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease

Serena Silvestro, Giovanni Schepici, Placido Bramanti, Emanuela Mazzon

Cannabidiol Oral Solution – A New Class of Antiseizure Medication

Simona Lattanzi, Eugen Trinka, Pasquale Striano, Francesco Brigo

European Neurological Review.2020; 15(1): 19. CrossRef

Current state of knowledge on the use of medical marijuana in some neurological diseases

Katarzyna Ziętal, Ilona Joniec-Maciejak, Dagmara Mirowska-Guzel

Pharmacotherapy in Psychiatry and Neurology.2020; 36(3): 205. CrossRef

Medical cannabis: A new frontier for pharmacists

Cannabis for musculoskeletal pain and arthritis: Evidence is needed

The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs

Victor Navarrete-Modesto, Sandra Orozco-Suárez, Iris A. Feria-Romero, Luisa Rocha

Cannabis‐based products for pediatric epilepsy: A systematic review

Jesse Elliott, Deirdre DeJean, Tammy Clifford, Doug Coyle, Beth K. Potter, Becky Skidmore, Christine Alexander, Alexander E. Repetski, Vijay Shukla, Bláthnaid McCoy, George A. Wells

Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol

Paula B. Dall'Stella, Marcos F. L. Docema, Marcos V. C. Maldaun, Olavo Feher, Carmen L. P. Lancellotti

Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine

Ivan Urits, Matthew Borchart, Morgan Hasegawa, Justin Kochanski, Vwaire Orhurhu, Omar Viswanath

Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder

Tristan Dale, Jenny Downs, Heather Olson, Ann Marie Bergin, Stephanie Smith, Helen Leonard

A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential

The Journal of Clinical Pharmacology.2019; 59(7): 923. CrossRef

Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects

What is the role of cannabidiol in refractory epilepsy?

Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain

Yedukondalu Nalli, Mohd Saleem Dar, Nasima Bano, Javeed Ur Rasool, Aminur R. Sarkar, Junaid Banday, Aadil Qadir Bhat, Basit Rafia, Ram A Vishwakarma, Mohd Jamal Dar, Asif Ali

Bioorganic & Medicinal Chemistry Letters.2019; 29(9): 1043. CrossRef

Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity

Éric Samarut, Jessica Nixon, Uday P. Kundap, Pierre Drapeau, Lee D. Ellis

Ontogeny and programming of the fetal temporal cortical endocannabinoid system by moderate maternal nutrient reduction in baboons ( Papio spp.)

Kushal Gandhi, Vanessa Montoya‐Uribe, Stacy Martinez, Samuel David, Bobby Jain, Grace Shim, Cun Li, Susan Jenkins, Peter Nathanielsz, Natalia Schlabritz‐Loutsevitch

Physiological Reports.2019; 7(6): e14024. CrossRef

Lung alveolar tissue destruction and protein citrullination in diesel exhaust‐exposed mouse lungs

Ieva Kulvinskiene, Jovile Raudoniute, Edvardas Bagdonas, Darius Ciuzas, Karina Poliakovaite, Inga Stasiulaitiene, Danguole Zabulyte, Daiva Bironaite, Petras Rimantas Venskutonis, Dainius Martuzevicius, Ruta Aldonyte

Basic & Clinical Pharmacology & Toxicology.2019; 125(2): 166. CrossRef

Le cannabis dans les douleurs musculosquelettiques et articulaires : des preuves sont nécessaires

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist

Richard C. Kevin, Lyndsey Anderson, Iain S. McGregor, Rochelle Boyd, Jamie J. Manning, Michelle Glass, Mark Connor, Samuel D. Banister

Effects of cannabidiol on brivaracetam plasma levels

Kerstin A. Klotz, Martin Hirsch, Marcel Heers, Andreas Schulze‐Bonhage, Julia Jacobs

Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy

From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome?

Francisco Melo Mouro, Catarina Miranda-Lourenço, Ana Maria Sebastião, Maria José Diógenes

Boulenouar Mesraoua, Dirk Deleu, Dimitri M. Kullmann, Ashok K. Shetty, Paul Boon, Emilio Perucca, Mohamad A. Mikati, Ali A. Asadi-Pooya

Use of complementary and alternative medicine among adults with epilepsy in a university epilepsy clinic in Poland

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy

Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies

Katarzyna Socała, Elżbieta Wyska, Małgorzata Szafarz, Dorota Nieoczym, Piotr Wlaź

Cannabis : enjeux et risques en médecine de la douleur

Cannabis-based treatments as an alternative remedy for epilepsy

Integrative Medicine Research.2019; 8(3): 200. CrossRef

Zeitschrift für Epileptologie.2019; 32(4): 286. CrossRef

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions

Lyndsey L. Anderson, Nathan L. Absalom, Sarah V. Abelev, Ivan K. Low, Peter T. Doohan, Lewis J. Martin, Mary Chebib, Iain S. McGregor, Jonathon C. Arnold

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy

Kerstin A. Klotz, Daniel Grob, Martin Hirsch, Birgitta Metternich, Andreas Schulze-Bonhage, Julia Jacobs

The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids

Keith A. Kwan Cheung, Hassendrini Peiris, Geoffrey Wallace, Olivia J. Holland, Murray D. Mitchell

International Journal of Molecular Sciences.2019; 20(23): 6079. CrossRef

Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective

T. Rasche, D. Emmert, C. Stieber, M. Mücke, R. Conrad

Integrative Palliative Care and Management of Refractory Epilepsy

Current Pediatrics Reports.2018; 6(2): 178. CrossRef

Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview

G. M. Mandolini, M. Lazzaretti, A. Pigoni, L. Oldani, G. Delvecchio, P. Brambilla

Epidemiology and Psychiatric Sciences.2018; 27(4): 327. CrossRef

Investigational cannabinoids in seizure disorders, what have we learned thus far?

Dejana Ružić Zečević, Marko Folić, Ziyad Tantoush, Milan Radovanović, Goran Babić, Slobodan M. Janković

Expert Opinion on Investigational Drugs.2018; 27(6): 535. CrossRef

Chemico-Biological Interactions.2018; 293: 77. CrossRef

Lewis-Acid-Mediated Union of Epoxy-Carvone Diastereomers with Anisole Derivatives: Mechanistic Insight and Application to the Synthesis of Non-natural CBD Analogues

Sophia J. Bailey, Rishi R. Sapkota, Alexandra E. Golliher, Barry Dungan, Marat Talipov, F. Omar Holguin, William A. Maio

Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis

Simona Lattanzi, Francesco Brigo, Claudia Cagnetti, Eugen Trinka, Mauro Silvestrini

Cannabis for the Treatment of Epilepsy: an Update

Current Neurology and Neuroscience Reports.2018;[Epub] CrossRef

Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey

Kerstin A. Klotz, Andreas Schulze-Bonhage, Victoria San Antonio-Arce, Julia Jacobs

Cannabinoids in the Treatment of Autism Spectrum Disorder: Demanding Data Before Using Fad Therapies

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor

María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés-Montero, Javier Garzón, Pilar Sánchez-Blázquez

Managing Antiepileptic Medication in Dialysis Patients

Current Treatment Options in Neurology.2018;[Epub] CrossRef

Expert Opinion on Emerging Drugs.2018; 23(3): 243. CrossRef

A novel GABAergic dysfunction in human Dravet syndrome

Gabriele Ruffolo, Pierangelo Cifelli, Cristina Roseti, Maria Thom, Erwin A. van Vliet, Cristina Limatola, Eleonora Aronica, Eleonora Palma

The pharmacological management of Lennox-Gastaut syndrome and critical literature review

Alberto Verrotti, Pasquale Striano, Giulia Iapadre, Luca Zagaroli, Paolo Bonanni, Giangennaro Coppola, Maurizio Elia, Oriano Mecarelli, Emilio Franzoni, Paola De Liso, Federico Vigevano, Paolo Curatolo